Scholars Central

Conference abstractPublished 26 Oct 2015

Cost-effective clinical trial design to detect immunogenicity and efficacy differences between biosimilar and innovator product

Authors: Candida Fratazzi

BBCR Consulting, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bio-therapeutic products are the fastest growing medicines in the pharmaceutical market. Here, we discuss the major variables that have an impact on cost and timelines of biosimilarsâÂ?Â? development. Specifically, we report the challenges of duplicating the innovator product results and how the dialogue on indication extrapolation has elicited new interest as the FDA compares extrapolationâÂ?Â?s core issues. According to the WHO, âÂ?Â?it is expected that the elaboration of the data requirements and considerations for the licensing of biosimilar products will facilitate development and worldwide access to bio-therapeutics of assured quality, safety and efficacy at more affordable pricesâÂ?. To address the WHO requirements, we have reviewed trial options that could assess interchangeability between the branded product and the biosimilar. Here, we discuss a case study with the objective of assessing the immunogenicity rate between biosimilar and innovator product and evaluate the data in light of regulatory requirements. Our developed framework based on evidence-based strategies and design-centered trials highlights the factors impacting the potential cost savings in biosimilar development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • SubjectImmunology & Microbiology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Candida Fratazzi”